10x Genomics is a leader in spatial biology and single-cell sequencing technologies, providing integrated instruments, consumables, and software for analyzing biological systems. The company develops the Xenium Analyzer platform for high-resolution spatial transcriptomics and RNA sequencing solutions (Chromium, Visium) for academic, government, biopharmaceutical, biotechnology, and research institutions globally.
10x Genomics is publicly traded
IPO'd on September 12, 2019
This company is no longer available on our private secondary market. Shares can be traded publicly under TXG.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2012
Employees
1,100–1,250
Serge Saxonov
Co-Founder and Chief Executive Officer
Ben Hindson
Co-Founder, Chief Scientific Officer, and President
Kevin Ness
Co-Founder
Justin McAnear
Chief Financial Officer
Michael Schnall-Levin
Chief Technology Officer, Founding Scientist
Brad Crutchfield
Chief Commercial Officer
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Illumina
DNA sequencing and genomic analysis technology provider
Thermo Fisher Scientific
Life sciences technology and genomics solutions provider
BGI Genomics
Chinese genomics sequencing company
Yes, 10x Genomics is publicly traded under the ticker symbol TXG on the NASDAQ. The company went public in September 12, 2019.
10x Genomics trades under the ticker symbol TXG on the NASDAQ. It began trading in September 12, 2019.
10x Genomics (TXG on the NASDAQ) shares can be purchased through any standard brokerage account — including Fidelity, Charles Schwab, TD Ameritrade, and online platforms like Robinhood or E*TRADE. Search for the ticker TXG to place an order.
10x Genomics went public in September 12, 2019 via ipo. 10x Genomics completed its IPO on September 12, 2019, pricing 9 million shares at $39 per share on the NASDAQ under ticker TXG. The stock surged 49% on first day of trading, opening at $54 and closing at $53.
10x Genomics was co-founded by Serge Saxonov, Ben Hindson, and Kevin Ness in 2012.
10x Genomics is headquartered in Pleasanton, California, United States.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.